Predicting antibody–antigen affinity with a dual-level representation model
Bioinformatics · 07.04.2026 · 42 (4)
DOI: 10.1093/bioinformatics/btag109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 10.03.2026. Verfasst von Ziyang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Artificial Intelligence, Xiamen University, Xiamen, 361102, China. Hauptthemen laut MEDLINE: Antibody Affinity, Deep Learning, Antibodies, Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of Chin, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Major Science and Technology Project of Fujian Provincial Health Commission.
Abstract (Originalsprache)
Motivation Protein language models are critical for modeling antibody–antigen interactions, yet sequence-based affinity prediction remains a key challenge, particularly when structural data are scarce. Existing methods often struggle to fully exploit sequence information, limiting their applicability across diverse antibody formats such as single-domain antibodies (sdAbs). Results We propose dual-level protein representation for affinity prediction (DLP-Affinity), a dual-level deep learning framework for accurate sequence-based affinity prediction. It leverages two complementary modules: residue-to-residue to capture local interface contacts, and global stochastic projection embedding to represent global protein properties. Utilizing a fine-tuned protein language model, our approach achieves state-of-the-art performance on the general AB-Bind dataset (reducing mean absolute error by up to 20.9%) and delivers highly competitive results on the sdAb-DB dataset. This provides a robust tool for sequence-based antibody affinity prediction. Availability and implementation The source code and datasets for DLP-Affinity are freely available at https://github.com/Zy-Wang-bit/DLP_Affinity and archived on Zenodo at https://doi.org/10.5281/zenodo.18437656
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Artificial Intelligence, Xiamen University, Xiamen, 361102, China.
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation P…
- Information and Networking Center, Xiamen University, Xiamen, 361102, China.
- School of Informatics, Xiamen University, Xiamen, 361102, China.
ORCID-Profile: Ziyang Wang, Yu Zhang, Jianwei Huang, Jun Zhang
Förderung
- National Natural Science Foundation of Chin
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Major Science and Technology Project of Fujian Provincial Health Commission
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Z., Zhang, Y., Zhang, Y., Huang, J., Lu, X., Min, X., Ge, S., Zhang, J., & Xia, N. (2026). Predicting antibody–antigen affinity with a dual-level representation model. Bioinformatics, 42(4). https://doi.org/10.1093/bioinformatics/btag109
Vancouver
Wang Z, Zhang Y, Zhang Y, Huang J, Lu X, Min X, et al. Predicting antibody–antigen affinity with a dual-level representation model. Bioinformatics. 2026;42(4). doi:10.1093/bioinformatics/btag109
BibTeX
@article{Wang2026,
author = {Wang, Ziyang and Zhang, Yu and Zhang, Youli and Huang, Jianwei and Lu, Xiaoli and Min, Xiaoping and Ge, Shengxiang and Zhang, Jun and Xia, Ningshao},
title = {Predicting antibody–antigen affinity with a dual-level representation model},
journal = {Bioinformatics},
year = {2026},
volume = {42},
number = {4},
doi = {10.1093/bioinformatics/btag109}
}
EUVIMED